Lewis Pang1, Kevin C Colclough1, Maggie H Shepherd2,3, Joanne McLean4, Ewan R Pearson4, Sian Ellard1, Andrew T Hattersley2,3, Beverley M Shields2,3. 1. Genomics Laboratory, Royal Devon and Exeter NHS Foundation Trust, Exeter, U.K. 2. Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, U.K. 3. Exeter National Institute for Health Research Clinical Research Facility, Royal Devon and Exeter NHS Foundation Trust/University of Exeter Medical School, Exeter, U.K. 4. Population Health and Genomics, School of Medicine, University of Dundee, Dundee, U.K.
Abstract
OBJECTIVE: Maturity-onset diabetes of the young (MODY) is a rare monogenic form of diabetes. In 2009, >80% of U.K. cases were estimated to be misdiagnosed. Since then, there have been a number of initiatives to improve the awareness and detection of MODY, including education initiatives (Genetic Diabetes Nurse [GDN] project), the MODY probability calculator, and targeted next-generation sequencing (tNGS). We examined how the estimated prevalence of MODY and other forms of monogenic diabetes diagnosed outside the neonatal period has changed over time and how the initiatives have impacted case finding. RESEARCH DESIGN AND METHODS: U.K. referrals for genetic testing for monogenic diabetes diagnosed >1 year of age from 1 January 1996 to 31 December 2019 were examined. Positive test rates were compared for referrals reporting GDN involvement/MODY calculator use with those that did not. RESULTS: A diagnosis of monogenic diabetes was confirmed in 3,860 individuals, more than threefold higher than 2009 (1 January 1996 to 28 February 2009, n = 1,177). Median age at diagnosis in probands was 21 years. GDN involvement was reported in 21% of referrals; these referrals had a higher positive test rate than those without GDN involvement (32% vs. 23%, P < 0.001). MODY calculator usage was indicated in 74% of eligible referrals since 2014; these referrals had a higher positive test rate than those not using the calculator (33% vs. 25%, P = 0.001). Four hundred ten (10.6%) cases were identified through tNGS. Monogenic diabetes prevalence was estimated to be 248 cases/million (double that estimated in 2009 because of increased case finding). CONCLUSIONS: Since 2009, referral rates and case diagnosis have increased threefold. This is likely to be the consequence of tNGS, GDN education, and use of the MODY calculator.
OBJECTIVE: Maturity-onset diabetes of the young (MODY) is a rare monogenic form of diabetes. In 2009, >80% of U.K. cases were estimated to be misdiagnosed. Since then, there have been a number of initiatives to improve the awareness and detection of MODY, including education initiatives (Genetic Diabetes Nurse [GDN] project), the MODY probability calculator, and targeted next-generation sequencing (tNGS). We examined how the estimated prevalence of MODY and other forms of monogenic diabetes diagnosed outside the neonatal period has changed over time and how the initiatives have impacted case finding. RESEARCH DESIGN AND METHODS: U.K. referrals for genetic testing for monogenic diabetes diagnosed >1 year of age from 1 January 1996 to 31 December 2019 were examined. Positive test rates were compared for referrals reporting GDN involvement/MODY calculator use with those that did not. RESULTS: A diagnosis of monogenic diabetes was confirmed in 3,860 individuals, more than threefold higher than 2009 (1 January 1996 to 28 February 2009, n = 1,177). Median age at diagnosis in probands was 21 years. GDN involvement was reported in 21% of referrals; these referrals had a higher positive test rate than those without GDN involvement (32% vs. 23%, P < 0.001). MODY calculator usage was indicated in 74% of eligible referrals since 2014; these referrals had a higher positive test rate than those not using the calculator (33% vs. 25%, P = 0.001). Four hundred ten (10.6%) cases were identified through tNGS. Monogenic diabetes prevalence was estimated to be 248 cases/million (double that estimated in 2009 because of increased case finding). CONCLUSIONS: Since 2009, referral rates and case diagnosis have increased threefold. This is likely to be the consequence of tNGS, GDN education, and use of the MODY calculator.
Authors: Stephanie R Johnson; Jonathan J Ellis; Paul J Leo; Lisa K Anderson; Uma Ganti; Jessica E Harris; Jacqueline A Curran; Aideen M McInerney-Leo; Nirubasini Paramalingam; Xiaoxia Song; Louise S Conwell; Mark Harris; Timothy W Jones; Matthew A Brown; Elizabeth A Davis; Emma L Duncan Journal: Pediatr Diabetes Date: 2018-11-14 Impact factor: 4.866
Authors: Maggie Shepherd; Beverley Shields; Suzanne Hammersley; Michelle Hudson; Timothy J McDonald; Kevin Colclough; Richard A Oram; Bridget Knight; Christopher Hyde; Julian Cox; Katherine Mallam; Christopher Moudiotis; Rebecca Smith; Barbara Fraser; Simon Robertson; Stephen Greene; Sian Ellard; Ewan R Pearson; Andrew T Hattersley Journal: Diabetes Care Date: 2016-06-06 Impact factor: 19.112
Authors: Sue Richards; Nazneen Aziz; Sherri Bale; David Bick; Soma Das; Julie Gastier-Foster; Wayne W Grody; Madhuri Hegde; Elaine Lyon; Elaine Spector; Karl Voelkerding; Heidi L Rehm Journal: Genet Med Date: 2015-03-05 Impact factor: 8.822
Authors: Anna M Steele; Beverley M Shields; Kirsty J Wensley; Kevin Colclough; Sian Ellard; Andrew T Hattersley Journal: JAMA Date: 2014-01-15 Impact factor: 56.272
Authors: S Ellard; H Lango Allen; E De Franco; S E Flanagan; G Hysenaj; K Colclough; J A L Houghton; M Shepherd; A T Hattersley; M N Weedon; R Caswell Journal: Diabetologia Date: 2013-06-15 Impact factor: 10.122
Authors: Sílvia Santos Monteiro; Tiago da Silva Santos; Liliana Fonseca; Guilherme Assunção; Ana M Lopes; Diana B Duarte; Ana Rita Soares; Francisco Laranjeira; Isaura Ribeiro; Eugénia Pinto; Sónia Rocha; Sofia Barbosa Gouveia; María Eugenia Vazquez-Mosquera; Maria João Oliveira; Teresa Borges; Maria Helena Cardoso Journal: Acta Diabetol Date: 2022-10-08 Impact factor: 4.087